Cargando…

Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients

Background and purpose — Hip arthroplasty is one of the most performed surgeries in Sweden, and the rate of adverse events (AEs) is fairly high. All patients in publicly financed healthcare in Sweden are insured by the Mutual Insurance Company of Swedish County Councils (Löf). We assessed the propor...

Descripción completa

Detalles Bibliográficos
Autores principales: Magnéli, Martin, Unbeck, Maria, Samuelsson, Bodil, Rogmark, Cecilia, Rolfson, Ola, Gordon, Max, Sköldenberg, Olof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Hip
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006721/
https://www.ncbi.nlm.nih.gov/pubmed/31615309
http://dx.doi.org/10.1080/17453674.2019.1677382
_version_ 1783495200455262208
author Magnéli, Martin
Unbeck, Maria
Samuelsson, Bodil
Rogmark, Cecilia
Rolfson, Ola
Gordon, Max
Sköldenberg, Olof
author_facet Magnéli, Martin
Unbeck, Maria
Samuelsson, Bodil
Rogmark, Cecilia
Rolfson, Ola
Gordon, Max
Sköldenberg, Olof
author_sort Magnéli, Martin
collection PubMed
description Background and purpose — Hip arthroplasty is one of the most performed surgeries in Sweden, and the rate of adverse events (AEs) is fairly high. All patients in publicly financed healthcare in Sweden are insured by the Mutual Insurance Company of Swedish County Councils (Löf). We assessed the proportion of patients that sustained a major preventable AE and filed an AE claim to Löf. Patients and methods — We performed retrospective record review using the Global Trigger Tool to identify AEs in a Swedish multi-center cohort consisting of 1,998 patients with a total or hemi hip arthroplasty. We compared the major preventable AEs with all patient-reported claims to Löf from the same cohort and calculated the proportion of filed claims. Results — We found 1,066 major preventable AEs in 744 patients. Löf received 62 claims for these AEs, resulting in a claim proportion of 8%. 58 of the 62 claims were accepted by Löf and received compensation. The claim proportion was 13% for the elective patients and 0.3% for the acute patients. The most common AE for filing a claim was periprosthetic joint infection; of the 150 infections found 37 were claimed. Interpretation — The proportion of filed claims for major preventable AEs is very low, even for obvious and serious AEs such as periprosthetic joint infection.
format Online
Article
Text
id pubmed-7006721
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-70067212020-02-20 Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients Magnéli, Martin Unbeck, Maria Samuelsson, Bodil Rogmark, Cecilia Rolfson, Ola Gordon, Max Sköldenberg, Olof Acta Orthop Hip Background and purpose — Hip arthroplasty is one of the most performed surgeries in Sweden, and the rate of adverse events (AEs) is fairly high. All patients in publicly financed healthcare in Sweden are insured by the Mutual Insurance Company of Swedish County Councils (Löf). We assessed the proportion of patients that sustained a major preventable AE and filed an AE claim to Löf. Patients and methods — We performed retrospective record review using the Global Trigger Tool to identify AEs in a Swedish multi-center cohort consisting of 1,998 patients with a total or hemi hip arthroplasty. We compared the major preventable AEs with all patient-reported claims to Löf from the same cohort and calculated the proportion of filed claims. Results — We found 1,066 major preventable AEs in 744 patients. Löf received 62 claims for these AEs, resulting in a claim proportion of 8%. 58 of the 62 claims were accepted by Löf and received compensation. The claim proportion was 13% for the elective patients and 0.3% for the acute patients. The most common AE for filing a claim was periprosthetic joint infection; of the 150 infections found 37 were claimed. Interpretation — The proportion of filed claims for major preventable AEs is very low, even for obvious and serious AEs such as periprosthetic joint infection. Taylor & Francis 2019-10-16 /pmc/articles/PMC7006721/ /pubmed/31615309 http://dx.doi.org/10.1080/17453674.2019.1677382 Text en © 2019 The Author(s). Published by Taylor & Francis on behalf of the Nordic Orthopedic Federation https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Hip
Magnéli, Martin
Unbeck, Maria
Samuelsson, Bodil
Rogmark, Cecilia
Rolfson, Ola
Gordon, Max
Sköldenberg, Olof
Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients
title Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients
title_full Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients
title_fullStr Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients
title_full_unstemmed Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients
title_short Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients
title_sort only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a swedish multi-center cohort study on 1,998 patients
topic Hip
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006721/
https://www.ncbi.nlm.nih.gov/pubmed/31615309
http://dx.doi.org/10.1080/17453674.2019.1677382
work_keys_str_mv AT magnelimartin only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients
AT unbeckmaria only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients
AT samuelssonbodil only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients
AT rogmarkcecilia only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients
AT rolfsonola only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients
AT gordonmax only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients
AT skoldenbergolof only8ofmajorpreventableadverseeventsafterhiparthroplastyarefiledasclaimsaswedishmulticentercohortstudyon1998patients